Search clinical trials for: LY2979165

Total 4 results

Eli Lilly and Company

Completed

A Study of LY2979165 in Healthy Subjects

Bipolar Disorder

Singapore
Eli Lilly and Company

Completed

A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy Volunteers

Bipolar Disorder

Singapore
Mediti Pharma Inc.

Terminated

A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Aggression | Dementia | Psychosis | Agitation | Alzheimer Dementia

United States, Canada
Eli Lilly and Company

Completed

A Study of LY2979165 and LY2140023 in Healthy Volunteers

Healthy Volunteers

United Kingdom

3

Subscribe